Glaucoma, Open Angle
13
1
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
38%
5 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (13)
Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty
DSLT in Normal Tension Glaucoma (NTG) Asian Eyes
SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients
Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension
A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma
AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma
SOLX Gold Shunt for Refractory Glaucoma
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments.
SOLX Titanium Sapphire Laser for Trabeculoplasty
Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma